Thursday, May 26, 2016

BRIEF-Aviragen delays further enrollment phase 2A trial for drug to treat RSV infections

* Voluntarily decided to delay further enrollment in phase

2a trial of bta585 for treatment of RSV infections being

conducted in U.K

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)